Roger H Herzig
Overview
Explore the profile of Roger H Herzig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krem M, Reynolds S, Hashmi H, Manapuram S, Jayswal R, Weiss H, et al.
Bone Marrow Transplant
. 2019 Nov;
55(7):1451-1453.
PMID: 31705039
No abstract available.
2.
Jacobsohn D, Arora M, Klein J, Hassebroek A, Flowers M, Cutler C, et al.
Blood
. 2011 Sep;
118(16):4472-9.
PMID: 21878671
There is a paucity of information regarding the factors that affect nonrelapse mortality (NRM) and overall survival among children that develop chronic graft-versus-host disease (cGVHD). We performed multivariate analyses using...
3.
Lazarus H, Phillips G, Herzig R, Hurd D, Wolff S, Herzig G
J Clin Oncol
. 2008 May;
26(14):2240-3.
PMID: 18467711
No abstract available.
4.
Slone S, Ahmed Z, Cole L, Elin R, Martin A, Herzig R, et al.
Am J Clin Pathol
. 2005 Jun;
124(1):108-12.
PMID: 15923168
Positive pregnancy test results occurred in a nongravid, premenopausal woman while she was receiving chemotherapy for multiple myeloma. We tested 2 hypotheses to account for this finding: (1) Heterophil antibodies...
5.
Zhai Q, Qiu L, Li Q, Meng H, Han J, Herzig R, et al.
Haematologica
. 2004 Mar;
89(3):265-73.
PMID: 15020263
Background And Objectives: The homing of stem cells to the bone marrow microenvironment following transplantation is a specific movement eventually leading to the stem cells lodging in specialized niches of...
6.
Vose J, Rizzo D, Tao-Wu J, Armitage J, Bashey A, Burns L, et al.
Biol Blood Marrow Transplant
. 2004 Jan;
10(2):116-27.
PMID: 14750077
We evaluated the results of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with diffuse aggressive non-Hodgkin lymphoma (NHL) in first relapse (Rel 1) or second complete remission...
7.
Fleming D, Ziegler C, Baize T, Mudd L, Goldsmith G, Herzig R
Am J Clin Oncol
. 2003 Jun;
26(3):285-8.
PMID: 12796602
An open labeled randomized trial comparing the efficacy and cost of empirically applied cefepime (C) as monotherapy versus combination therapy consisting of ticarcillin and clavulanate potassium and aztreonam (T/A) was...
8.
Pecora A, Lazarus H, Jennis A, Preti R, Goldberg S, Rowley S, et al.
Biol Blood Marrow Transplant
. 2002 Nov;
8(10):536-43.
PMID: 12434948
The incidence and clinical relevance of tumor cells contaminating the stem cell products of patients with advanced breast cancer treated with high-dose chemotherapy is uncertain because prior studies used small...
9.
Metayer C, Curtis R, Vose J, Sobocinski K, Horowitz M, Bhatia S, et al.
Blood
. 2002 Oct;
101(5):2015-23.
PMID: 12393427
Although numerous reports indicate that patients receiving autotransplants for lymphoma are at increased risk for myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML), the separate contributions of pretransplantation- and transplantation-related therapy are...